Free Trial

Humacyte (HUMA) News Today

→ Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad)
Free HUMA Stock Alerts
$7.20
-0.07 (-0.96%)
(As of 05:45 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends
June 6, 2024 | americanbankingnews.com
Brady W. Dougan Acquires 2,362 Shares of Humacyte, Inc. (NASDAQ:HUMA) Stock
June 6, 2024 | americanbankingnews.com
Humacyte (NASDAQ:HUMA) Trading Down 14.8% on Insider Selling
June 5, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Stock Price Up 10.9%
Humacyte (NASDAQ:HUMA) Trading Up 10.9%
June 5, 2024 | insidertrades.com
Humacyte, Inc. (NASDAQ:HUMA) Director Buys $14,998.70 in Stock
June 5, 2024 | americanbankingnews.com
Humacyte, Inc. (NASDAQ:HUMA) CEO Laura E. Niklason Sells 809,786 Shares
June 5, 2024 | americanbankingnews.com
Heather Ledbetter Prichard Sells 188,886 Shares of Humacyte, Inc. (NASDAQ:HUMA) Stock
June 4, 2024 | marketbeat.com
Humacyte, Inc. (NASDAQ:HUMA) Director Brady W. Dougan Purchases 2,362 Shares
Humacyte, Inc. (NASDAQ:HUMA - Get Free Report) Director Brady W. Dougan bought 2,362 shares of the company's stock in a transaction that occurred on Tuesday, June 4th. The shares were purchased at an average cost of $6.35 per share, for a total transaction of $14,998.70. Following the acquisition, the director now owns 240,832 shares of the company's stock, valued at $1,529,283.20. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
June 4, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Shares Down 14.8% on Insider Selling
Humacyte (NASDAQ:HUMA) Shares Down 14.8% on Insider Selling
June 4, 2024 | americanbankingnews.com
Short Interest in Humacyte, Inc. (NASDAQ:HUMA) Decreases By 6.7%
June 4, 2024 | insidertrades.com
Humacyte, Inc. (NASDAQ:HUMA) CEO Acquires $15,108.50 in Stock
June 3, 2024 | marketbeat.com
Humacyte, Inc. (NASDAQ:HUMA) CEO Laura E. Niklason Buys 2,050 Shares
Humacyte, Inc. (NASDAQ:HUMA - Get Free Report) CEO Laura E. Niklason acquired 2,050 shares of the stock in a transaction dated Monday, June 3rd. The stock was acquired at an average cost of $7.37 per share, with a total value of $15,108.50. Following the completion of the transaction, the chief executive officer now owns 238,470 shares in the company, valued at approximately $1,757,523.90. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link.
June 3, 2024 | marketbeat.com
Humacyte, Inc. (NASDAQ:HUMA) Sees Large Drop in Short Interest
Humacyte, Inc. (NASDAQ:HUMA - Get Free Report) saw a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 4,190,000 shares, a decline of 6.7% from the April 30th total of 4,490,000 shares. Approximately 4.6% of the shares of the stock are sold short. Based on an average daily volume of 1,740,000 shares, the short-interest ratio is presently 2.4 days.
June 2, 2024 | americanbankingnews.com
Humacyte (NASDAQ:HUMA) Shares Gap Up to $9.10
May 30, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Sees Large Volume Increase
Humacyte (NASDAQ:HUMA) Sees Strong Trading Volume
May 30, 2024 | globenewswire.com
Humacyte to Present at the Jefferies Global Healthcare Conference
May 29, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Sets New 12-Month High at $7.80
Humacyte (NASDAQ:HUMA) Hits New 52-Week High at $7.80
May 24, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Receives Buy Rating from Benchmark
Benchmark reaffirmed a "buy" rating and issued a $15.00 price target on shares of Humacyte in a research note on Friday.
May 22, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Trading 7.3% Higher
Humacyte (NASDAQ:HUMA) Shares Up 7.3%
May 21, 2024 | finance.yahoo.com
This Humacyte Insider Increased Their Holding By 91% Last Year
May 20, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Hits New 12-Month High at $7.10
Humacyte (NASDAQ:HUMA) Reaches New 1-Year High at $7.10
May 17, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Shares Down 3.4%
Humacyte (NASDAQ:HUMA) Trading Down 3.4%
May 17, 2024 | insidertrades.com
Gordon M. Binder Purchases 50,000 Shares of Humacyte, Inc. (NASDAQ:HUMA) Stock
May 16, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Shares Up 6.2% After Insider Buying Activity
Humacyte (NASDAQ:HUMA) Shares Up 6.2% on Insider Buying Activity
May 14, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Shares Gap Up to $5.48
Humacyte (NASDAQ:HUMA) Shares Gap Up to $5.48
May 14, 2024 | msn.com
Humacyte extends gains as FDA reviews blood vessel product
May 13, 2024 | markets.businessinsider.com
Benchmark Co. Keeps Their Buy Rating on Humacyte (HUMA)
May 13, 2024 | msn.com
Humacyte, Inc. (NASDAQ:HUMA) Q1 2024 Earnings Call Transcript
May 13, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Hits New 12-Month High at $5.09
Humacyte (NASDAQ:HUMA) Reaches New 52-Week High at $5.09
May 13, 2024 | finance.yahoo.com
Humacyte Inc (HUMA) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...
May 13, 2024 | finance.yahoo.com
Humacyte to Participate at Upcoming Investor Conferences in May
May 13, 2024 | globenewswire.com
Humacyte to Participate at Upcoming Investor Conferences in May
May 11, 2024 | finance.yahoo.com
Q1 2024 Humacyte Inc Earnings Call
May 10, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Trading Up 6.2%
Humacyte (NASDAQ:HUMA) Shares Up 6.2%
May 10, 2024 | benzinga.com
Peering Into Humacyte's Recent Short Interest
May 10, 2024 | finance.yahoo.com
Humacyte Inc (HUMA) Q1 2024 Earnings: Aligns with Analyst Projections Amid Strategic Advances
May 10, 2024 | msn.com
Humacyte GAAP EPS of -$0.29 misses by $0.06
May 10, 2024 | globenewswire.com
Humacyte First Quarter 2024 Financial Results and Business Update
May 9, 2024 | msn.com
Humacyte Q1 2024 Earnings Preview
May 7, 2024 | marketbeat.com
Humacyte (HUMA) to Release Quarterly Earnings on Friday
Humacyte (NASDAQ:HUMA) will be releasing earnings before the market opens on Friday, May 10, Zacks reports.
May 6, 2024 | globenewswire.com
Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 10, 2024
May 1, 2024 | marketbeat.com
Humacyte (NASDAQ:HUMA) Trading Up 7.4%
Humacyte (NASDAQ:HUMA) Stock Price Up 7.4%
April 20, 2024 | msn.com
A U.S. Senator Just Bought this Tiny Stock – It’s Up 15% Today
April 18, 2024 | msn.com
A U.S. Senator Just Bought this Tiny Stock - It's Up 15% Today
April 18, 2024 | benzinga.com
Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday
April 18, 2024 | msn.com
Tuberville’s Trading Raises Questions: Senator Sells Put Options, Invests in Small Biotech Tied to Ukraine-Russia Conflict
April 17, 2024 | ca.investing.com
U.S. Senator Tommy Tuberville Just Reported a Purchase of $HUMA stock
April 15, 2024 | finance.yahoo.com
Humacyte, Inc. (HUMA) Interactive Stock Chart - Yahoo Finance
April 8, 2024 | markets.businessinsider.com
Oppenheimer Keeps Their Buy Rating on Humacyte (HUMA)
April 4, 2024 | marketbeat.com
Research Analysts Set Expectations for Humacyte, Inc.'s FY2024 Earnings (NASDAQ:HUMA)
Humacyte, Inc. (NASDAQ:HUMA - Free Report) - Equities research analysts at Cantor Fitzgerald upped their FY2024 earnings per share estimates for Humacyte in a research report issued to clients and investors on Monday, April 1st. Cantor Fitzgerald analyst K. Kluska now expects that the company wil
April 1, 2024 | marketbeat.com
Humacyte's (HUMA) Overweight Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reissued an "overweight" rating and issued a $7.00 target price on shares of Humacyte in a research report on Monday.
Get Humacyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for HUMA and its competitors with MarketBeat's FREE daily newsletter.

The #1 Crypto That You Don’t Own… Yet (Ad)

There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.

Click here for all the details…

HUMA Media Mentions By Week

HUMA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HUMA
News Sentiment
▼
0.67

0.76
▲
Average
Medical
News Sentiment

HUMA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HUMA Articles
This Week
▼
15

2
▲
HUMA Articles
Average Week

Get Humacyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for HUMA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:HUMA) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
Missed NVDA? Buy this AI stock NOW
After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...
Chaikin Analytics | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
Moonshot Coins for the Current Crypto Run
Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...
Crypto 101 Media | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored
RSVP: Charles Payne’s Cash Flow Workshop
Did you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...
Unstoppable Prosperity | Sponsored
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored